Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Total Current Liabilities
All obligations due within one year.
No reported Total Current Liabilities figures are available to summarize.
Total Current Liabilities history
Currency unavailable · from the balance sheet
No Total Current Liabilities data reported for this period type.
Total Current Liabilities vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $76.23M USD | -10.9% | +76.4% | 13.6% |
| Mar 2026 | $41.7M USD | -5.3% | +14.0% | 12.6% | |
| Sep 2026 | $40.14M USD | -13.2% | +58.8% | 3.7% | |
| Mar 2026 | $38.36M USD | +49.9% | +32.8% | 20.2% | |
| Jun 2026 | $37.18M USD | +4.7% | +13.4% | 4.2% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $31.78M USD | +51.6% | +138.6% | 2.6% |
| Mar 2026 | $27.37M USD | +27.2% | +9.3% | 13.8% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €9.51M EUR | — | — | 5.7% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +4.7% | +32.8% | 9.2% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.